GO Term |
---|
Golgi apparatus |
plasma membrane |
microvillus |
secretory granule membrane |
cell projection |
extracellular exosome |
basolateral plasma membrane |
apical plasma membrane |
lamellipodium membrane |
cytosol |
GO Term |
---|
transmembrane signaling receptor activity |
cytokine receptor activity |
collagen binding |
hyaluronic acid binding |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
199 |
|
|||
200 |
|
|||
271 |
|
|||
282 |
|
|
||
318 |
|
|||
325 |
|
|||
330 |
|
|||
332 |
|
|||
350 | N-linked (GlcNAc...) asparagine |
|
||
398 |
|
Pathway Name | Organism |
---|---|
Cell surface interactions at the vascular wall | Homo sapiens |
Degradation of the extracellular matrix | Homo sapiens |
Hyaluronan uptake and degradation | Homo sapiens |
Integrin cell surface interactions | Homo sapiens |
Interferon gamma signaling | Homo sapiens |
Neutrophil degranulation | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110186 | Charcot-Marie-Tooth disease type 4D | |
DOID:0110187 | Charcot-Marie-Tooth disease type 4K | |
DOID:0110190 | Charcot-Marie-Tooth disease type 4B2 | |
DOID:0110191 | Charcot-Marie-Tooth disease type 4B1 | |
DOID:0110192 | Charcot-Marie-Tooth disease type 4H | |
DOID:0110193 | Charcot-Marie-Tooth disease type 4F | |
DOID:0110194 | Charcot-Marie-Tooth disease type 4B3 | |
DOID:0110195 | Charcot-Marie-Tooth disease type 4E | |
DOID:0110196 | Charcot-Marie-Tooth disease type 4G | |
DOID:0110197 | Charcot-Marie-Tooth disease dominant intermediate B |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024